Literature DB >> 35476131

Malignant thyroid nodule topography as additional risk factor for lymph-node metastases in differentiated thyroid cancer patients.

Alfredo Campennì1, Massimiliano Siracusa2, Rosaria Maddalena Ruggeri3, Luca Giovanella4,5, Sergio Baldari2.   

Abstract

Entities:  

Keywords:  Differentiated thyroid cancer; Isthmus; Lymph-node metastasis; Malignant nodule topography; Risk factors

Year:  2022        PMID： 35476131     DOI： 10.1007/s00405-022-07411-w

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN： 0937-4477            Impact factor:   2.503


× No keyword cloud information.
  5 in total

1.  Is isthmic enucleo-resection a reliable treatment for isthmic differentiated thyroid carcinoma? A note of caution.

Authors:  A Campennì; R Piantanida; L Giovanella
Journal:  J Endocrinol Invest       Date:  2020-05-12       Impact factor: 4.256

2.  The localization of thyroid cancers on the thyroid gland is a new risk factor for metastases of perithyroidal, peritracheal and central lymph nodes.

Authors:  Özlem Karaca Ocak; Hasan Ergenc; Zeynep Ergenc; Feyzi Gökosmanoğlu
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-03-31       Impact factor: 2.503

3.  Is malignant nodule topography an additional risk factor for metastatic disease in low-risk differentiated thyroid cancer?

Authors:  Alfredo Campennì; Luca Giovanella; Massimiliano Siracusa; Maria Elena Stipo; Angela Alibrandi; Mariapaola Cucinotta; Rosaria M Ruggeri; Sergio Baldari
Journal:  Thyroid       Date:  2014-09-11       Impact factor: 6.568

4.  Isthmus topography is a risk factor for persistent disease in patients with differentiated thyroid cancer.

Authors:  Alfredo Campennì; Rosaria Maddalena Ruggeri; Massimiliano Siracusa; Giulia Giacoppo; Flavia La Torre; Angiola Saccomanno; Angela Alibrandi; Gianlorenzo Dionigi; Giovanni Tuccari; Sergio Baldari; Luca Giovanella
Journal:  Eur J Endocrinol       Date:  2021-08-03       Impact factor: 6.664

Review 5.  Personalized management of differentiated thyroid cancer in real life - practical guidance from a multidisciplinary panel of experts.

Authors:  Alfredo Campennì; Daniele Barbaro; Marco Guzzo; Francesca Capoccetti; Luca Giovanella
Journal:  Endocrine       Date:  2020-08-09       Impact factor: 3.633
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.